Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Clinical trial NCT00004036 · UNKNOWN

Trial details

NCT number: NCT00004036
Sponsor: The Cleveland Clinic
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Drug/Agent Toxicity by Tissue/Organ Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Precancerous Condition Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1997-11-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.